PMC:7377212 / 3455-3662
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T67","span":{"begin":83,"end":91},"obj":"Disease"},{"id":"T68","span":{"begin":138,"end":142},"obj":"Disease"}],"attributes":[{"id":"A67","pred":"mondo_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A68","pred":"mondo_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"}],"text":"teroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA. Importantly, the recent finding by the UK RECOVERY trial (ISRCT"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T24","span":{"begin":35,"end":38},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"teroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA. Importantly, the recent finding by the UK RECOVERY trial (ISRCT"}
MyTest
{"project":"MyTest","denotations":[{"id":"32703771-12890854-29390906","span":{"begin":12,"end":13},"obj":"12890854"},{"id":"32703771-32171076-29390907","span":{"begin":93,"end":94},"obj":"32171076"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"teroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA. Importantly, the recent finding by the UK RECOVERY trial (ISRCT"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T21","span":{"begin":16,"end":143},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"teroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA. Importantly, the recent finding by the UK RECOVERY trial (ISRCT"}
2_test
{"project":"2_test","denotations":[{"id":"32703771-12890854-29390906","span":{"begin":12,"end":13},"obj":"12890854"},{"id":"32703771-32171076-29390907","span":{"begin":93,"end":94},"obj":"32171076"}],"text":"teroid use [5]. Corticosteroid use has been reported in hospitalised patients with COVID-19 [1] and may further contribute to the risk of CAPA. Importantly, the recent finding by the UK RECOVERY trial (ISRCT"}